1. From the Multiple Sclerosis and Neuroimmunology Program (H.A.), University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH; and Center for Research on Neuroimmunological Diseases (CIEN) (M.F.F.), Fleni, Buenos Aires, Argentina.